US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist
  • 4.600
  • -0.220-4.56%
Close Dec 10 16:00 ET
268.22MMarket Cap-15.86P/E (TTM)

Vanda Pharmaceuticals Key Stats

Vanda Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 6, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
49.15M
47.65M
-1.50M
Miss Est.
+26.64%
+22.76%
-3.06%
EPS
-0.16
-0.09
+0.07
Beat Est.
--
-3883.10%
+44.85%
Buy

Nov 30, 2024

Vanda Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 52.248M--
May 3, 20232023/Q1-- / 62.500M--
Nov 6, 20242024/Q347.651M / 49.155M--
Jul 31, 20242024/Q250.474M / 47.860M--
Feb 7, 20242023/Q445.271M / 37.000M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 52.248M--
May 3, 20232023/Q1-- / 62.500M--
Nov 6, 20242024/Q347.651M / 49.155M--
Jul 31, 20242024/Q250.474M / 47.860M--
Feb 7, 20242023/Q445.271M / 37.000M--

Unlock Free Earnings Estimates

Vanda Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Nov 30, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Price
% Chg

No Data